Terms: = Cervical cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
103 results:
1. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract] [Full Text] [Related]
2. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
Fan Z; Sun X; Han X; Sun C; Huang D
Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
[TBL] [Abstract] [Full Text] [Related]
4. SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion
Xu D; Feng H; Ren Z; Li X; Jiang C; Chen Y; Liu L; Chen W; Cui Z; Cang S
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):744-753. PubMed ID: 38035707
[TBL] [Abstract] [Full Text] [Related]
5. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
Deng Y; Dong Y; Wu L; Zhang Q; Yang L
Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
[TBL] [Abstract] [Full Text] [Related]
6. Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
Yang X; Sun F; Gao Y; Li M; Liu M; Wei Y; Jie Q; Wang Y; Mei J; Mei J; Ma L; Shi Y; Chen M; Li Y; Li Q; Liu M; Ma Y
J Exp Clin Cancer Res; 2023 Oct; 42(1):268. PubMed ID: 37845756
[TBL] [Abstract] [Full Text] [Related]
7. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
[TBL] [Abstract] [Full Text] [Related]
8. GLDC promotes colorectal cancer metastasis through epithelial-mesenchymal transition mediated by Hippo signaling pathway.
Yu H; Hu X; Zhang Y; Wang J; Ni Z; Wang Y; Zhu H
Med Oncol; 2023 Sep; 40(10):293. PubMed ID: 37668829
[TBL] [Abstract] [Full Text] [Related]
9. The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
Zhang M; Hong X; Ma N; Wei Z; Ci X; Zhang S
J Transl Med; 2023 Jul; 21(1):433. PubMed ID: 37403143
[TBL] [Abstract] [Full Text] [Related]
10. LINC00426, a novel m
Shen S; Jin H; Zhang X; Zhang Y; Li X; Yan W; Xie S; Yu B; Hu J; Liu H; Chen X; Nie Y; Liu F; Tang M; Gu Y; Wang S
Cell Signal; 2023 Sep; 109():110788. PubMed ID: 37392859
[TBL] [Abstract] [Full Text] [Related]
11. TGF-β signaling promotes cervical cancer metastasis via CDR1as.
Zhong G; Zhao Q; Chen Z; Yao T
Mol Cancer; 2023 Mar; 22(1):66. PubMed ID: 37004067
[TBL] [Abstract] [Full Text] [Related]
12. Effects of Fractionated Radiation Exposure on Vimentin Expression in cervical cancers: Analysis of Association with cancer Stem Cell Response and Short-Term prognosis.
Zamulaeva I; Matchuk O; Selivanova E; Mkrtchian L; Yakimova A; Gusarova V; Lipunov N; Krikunova L; Ivanov S; Kaprin A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834676
[TBL] [Abstract] [Full Text] [Related]
13. LMCD1-AS1 Facilitates Cell Proliferation and emt by Sponging miR-873-3p in cervical cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract] [Full Text] [Related]
14. Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, emt and Stemness in ER+ cancer Cells.
Diaz-Ruano AB; Martinez-Alarcon N; Perán M; Benabdellah K; Garcia-Martinez MLÁ; Preda O; Ramirez-Tortosa C; Gonzalez-Hernandez A; Marchal JA; Picon-Ruiz M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674737
[TBL] [Abstract] [Full Text] [Related]
15. Dysregulated RUNX1 Predicts Poor prognosis by Mediating Epithelialmesenchymal Transition in cervical cancer.
Zheng LL; Cai L; Zhang XQ; Lei Z; Yi CS; Liu XD; Yang JG
Curr Med Sci; 2022 Dec; 42(6):1285-1296. PubMed ID: 36544038
[TBL] [Abstract] [Full Text] [Related]
16. Endothelial cell-specific molecule 1 drives cervical cancer progression.
Lu J; Liu Q; Zhu L; Liu Y; Zhu X; Peng S; Chen M; Li P
Cell Death Dis; 2022 Dec; 13(12):1043. PubMed ID: 36522312
[TBL] [Abstract] [Full Text] [Related]
17. Insulin-induced gene 2 expression is associated with cervical adenocarcinoma malignant behavior.
Qian Y; Li X; Qiu J; Zhang R
Mol Biol Rep; 2023 Feb; 50(2):1553-1563. PubMed ID: 36515824
[TBL] [Abstract] [Full Text] [Related]
18. CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways.
Xin W; Zhang J; Zhang H; Ma X; Zhang Y; Li Y; Wang F
BMC Mol Cell Biol; 2022 Oct; 23(1):44. PubMed ID: 36280802
[TBL] [Abstract] [Full Text] [Related]
19. EFEMP2 increases the invasion ability of cervical cancer cells by promoting emt via the Raf/MEK/ERK signaling pathway.
Li N; Ji GX; Yang ZY
Neoplasma; 2022 Sep; 69(5):1185-1197. PubMed ID: 36004647
[TBL] [Abstract] [Full Text] [Related]
20. Can the combination of DWI and T2WI radiomics improve the diagnostic efficiency of cervical squamous cell carcinoma?
Wang S; Jiang T; Hu X; Hu H; Zhou X; Wei Y; Mao X; Zhao Z
Magn Reson Imaging; 2022 Oct; 92():197-202. PubMed ID: 35842193
[TBL] [Abstract] [Full Text] [Related]
[Next]
